The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of ...
March 3 (Reuters) - The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster ...
The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...
The health secretary announced his plans on the February 27 episode of the Joe Rogan Experience podcast, sharing that he wants to reverse a decision by the FDA that prohibited almost 20 peptides from ...
Scientific, political pressures colliding at FDA, delaying rare disease treatment for patients who have few or no options, experts said at CNBC Cures Summit.
March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims about compounded versions of popular GLP-1 ...
The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete ...
Pfizer CEO Albert Bourla said the company "has a problem" with the U.S. Food and Drug Administration's biologics and vaccines chief, Vinay Prasad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results